// App-Quantinova.ai

: Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4:14): The MD Anderson Cancer Center Experience

Researchers

Presenter

  • Oren Pasvolsky

Principal Investigators

  • Adeel Masood

  • Sophiya S Shehzad

  • Mark R Tanner

  • Qaiser Bashir

  • Samer A Srour

  • Neeraj Saini

  • Jeremy L. Ramdial

  • Yago Nieto

  • Hans C. Lee

  • Krina Patel

  • Partow Kebriaei

  • Sheeba K Thomas

  • Donna M. Weber

  • Robert Z. Orlowski

  • Elizabeth J Shpall

  • Richard E Champlin

  • Muzaffar H Qazilbash

Medical Centers

  • Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel

  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A